NanoRepro AG
NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. It offers rapid diagnostic tests, such as family planning, and preve… Read more
Market Cap & Net Worth: NanoRepro AG (NN6)
NanoRepro AG (XETRA:NN6) has a market capitalization of $18.71 Million (€18.23 Million) as of March 18, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #26266 globally and #2879 in its home market, demonstrating a -4.93% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NanoRepro AG's stock price €1.45 by its total outstanding shares 12613276 (12.61 Million).
NanoRepro AG Market Cap History: 2015 to 2026
NanoRepro AG's market capitalization history from 2015 to 2026. Data shows growth from $10.31 Million to $18.71 Million (5.90% CAGR).
NanoRepro AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NanoRepro AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.89x
NanoRepro AG's market cap is 3.89 times its annual revenue
0.69x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $10.31 Million | $607.67K | -$1.18 Million | 16.97x | N/A |
| 2016 | $10.02 Million | $1.85 Million | -$551.67K | 5.41x | N/A |
| 2017 | $14.52 Million | $1.97 Million | -$734.08K | 7.36x | N/A |
| 2018 | $10.56 Million | $2.75 Million | -$289.62K | 3.84x | N/A |
| 2019 | $7.52 Million | $1.22 Million | -$1.19 Million | 6.17x | N/A |
| 2020 | $40.89 Million | $16.93 Million | $1.69 Million | 2.42x | 24.13x |
| 2021 | $81.46 Million | $162.72 Million | $29.72 Million | 0.50x | 2.74x |
| 2022 | $26.72 Million | $38.49 Million | -$3.72 Million | 0.69x | N/A |
| 2023 | $25.83 Million | $3.18 Million | -$4.69 Million | 8.11x | N/A |
| 2024 | $18.06 Million | $4.65 Million | -$2.05 Million | 3.89x | N/A |
Competitor Companies of NN6 by Market Capitalization
Companies near NanoRepro AG in the global market cap rankings as of March 18, 2026.
Key companies related to NanoRepro AG by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
NanoRepro AG Historical Marketcap From 2015 to 2026
Between 2015 and today, NanoRepro AG's market cap moved from $10.31 Million to $ 18.71 Million, with a yearly change of 5.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €18.71 Million | -3.99% |
| 2025 | €19.49 Million | +7.89% |
| 2024 | €18.06 Million | -30.08% |
| 2023 | €25.83 Million | -3.33% |
| 2022 | €26.72 Million | -67.20% |
| 2021 | €81.46 Million | +99.20% |
| 2020 | €40.89 Million | +443.80% |
| 2019 | €7.52 Million | -28.79% |
| 2018 | €10.56 Million | -27.25% |
| 2017 | €14.52 Million | +44.90% |
| 2016 | €10.02 Million | -2.87% |
| 2015 | €10.31 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NanoRepro AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.71 Million USD |
| MoneyControl | $18.71 Million USD |
| MarketWatch | $18.71 Million USD |
| marketcap.company | $18.71 Million USD |
| Reuters | $18.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.